首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1423537

先進的給藥系統：全球市場與各種技術

Global Markets and Technologies for Advanced Drug Delivery Systems

出版日期: 2024年02月06日 | 出版商:

BCC Research | 英文 265 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球先進給藥系統市場規模預計將從2023年的2,626億美元成長到2028年終的3,591億美元，預測期間內複合年成長率為6.5%。

北美市場預計將從2023年的1,094億美元成長到年終的1,521億美元，同期複合年成長率為6.8%。此外，亞太市場預計將從2023年的477億美元成長到年終的686億美元，複合年成長率為7.5%。

該報告調查了先進藥物輸送系統的全球市場，並提供了市場概況、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析以及臨床試驗和專利趨勢。形勢、主要企業簡介等

Highlights:

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

North American market for advanced drug delivery systems is expected to increase from $109.4 billion in 2023 to $152.1 billion by the end of 2028, with a CAGR of 6.8% during the forecast period of 2023-2028.

Asia-Pacific market for advanced drug delivery systems is expected to increase from $47.7 billion in 2023 to $68.6 billion by the end of 2028, with a CAGR of 7.5% during the forecast period of 2023-2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for advanced drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions about drug deliveries.

This in-depth analysis of the global ADDS market includes historical data and market projections on sales by technology, route of administration, drug vehicles/carriers and application. The analysis describes the different types of ADDS technology (immediate-release drug delivery, extended-release drug delivery, targeted-release drug delivery, delayed-release drug delivery, and pulsatile-release drug delivery) and their current and historical market revenues. It also covers the route of administration of a drug delivery system and the source of a carrier mechanism for drug delivery. In addition, the report examines applications of ADDS (oncology, respiratory, inflammatory and allergies, cardiovascular, ophthalmic, central nervous system, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal disorders, dermatology, other).

The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.

Report Includes:

27 data tables and 93 additional tables
An overview of the global markets and technologies for advanced drug delivery systems (ADDS)
Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the market size and revenue forecast for the global ADDS market, and corresponding market share analysis based on technology, application (therapeutic area), route of administration, vehicle/carrier of drugs mechanism and geographic region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
Discussion of the importance of ESG in the ADDS market, including consumer attitudes, impact of ESG factors on company performance and ESG practices of leading companies
Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
Insight into the emerging technologies and developments in the ADDS market and clinical trial landscape
An analysis of the industry structure, including company market shares, recent M&A activity and venture funding
Analysis of the competitive landscape based on recent developments and the segmental revenues of leading vendors
Company profiles of major players within the industry, including Johnson & Johnson, Novartis AG, Pfizer Inc., Merck & Co. Inc., Medtronic, and Abbott.

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Highlights of the Market for Advanced Drug Delivery Systems

Chapter 3 Market Overview

Overview
Evolution of Advanced Drug Delivery Systems

Chapter 4 Market Dynamics

Overview
Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the ADDS Market

Chapter 5 Evaluation of the Market Based on Technology

Overview of Advanced Drug Delivery Systems and Technologies
Market Share and Forecast
Immediate-Release Drug Delivery
Extended-Release Drug Delivery
Targeted-Release Drug Delivery
Delayed-Release Drug Delivery
Pulsatile-Release Drug Delivery

Chapter 6 Evaluation of the Market Based on Route of Administration

Overview of Routes of Administration of Drugs
Market Share and Forecast
Oral
Parenteral/Injectable
Transmucosal
Transmucosal Nasal and Pulmonary
Transmucosal Ocular
Transmucosal Rectal
Transmucosal Oral Buccal
Transmucosal Vaginal
Implant
Transdermal
Topical

Chapter 7 Evaluation of the Market Based on Vehicle/Carrier

Overview of Vehicles/Carriers Used in Advanced Drug Delivery Systems
Market Share and Forecast
Nanoparticles
Monoclonal Antibodies
Liposomes
Polymeric Therapeutics
Dendrimers
Polymeric Drug
Polymeric Micelles
Prodrugs
Microparticles
Others

Chapter 8 Evaluation of the Market Based on Application

Overview of Applications Used in Advanced Drug Delivery Systems
Market Share and Forecast
Oncology
Inflammatory Diseases and Allergies
Cardiovascular
Ophthalmic
Central Nervous System
Hormone Replacement Therapy and Gynecology
Viral and Bacterial Diseases
Diabetes
Urology
Gastrointestinal (GI) Disorders
Dermatology
Respiratory
Other Therapeutic

Chapter 9 Evaluation of the Market Based on Geographic Region

Global Market for ADDS by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter 10 ESG Development

Introduction to ESG
Sustainability in the Advanced Drug Delivery Systems (ADDS) Industry: An ESG Perspective
Key ESG Issues
ESG Risk Rankings
Consumer Attitudes toward ESG in the ADDS Market
Case Study
Concluding Remarks from BCC

Chapter 11 Emerging Technologies in the Market

Emerging Technology, ADDS Market
3D Printing Technology in Drug Delivery
Biologics Drug Delivery
AI in Drug Delivery
Smart Drug Delivery System

Chapter 12 Clinical Trials and Patent Analysis

Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Clinical Trials Analysis by Region
Patent Analysis
Patents by Year
Patents by Top Applicant
Patents by Top Owner
Patents by Jurisdiction

Chapter 13 Competitive Intelligence

Market Share Analysis
Recent Developments of Key Market Players

Chapter 14 Company Profiles

ABBOTT
ABBVIE INC.
ASTRAZENECA
BD
BOSTON SCIENTIFIC CORP.
F. HOFFMANN-LA ROCHE LTD
JOHNSON & JOHNSON SERVICES INC.
KINDEVA DRUG DELIVERY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI S.A.
TERUMO CORP.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter 15 Appendix: Acronyms

簡介目錄圖表

List of Tables

Summary Table A : Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
Summary Table B : Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
Table 1 : Global Market for Advanced Drug Delivery Systems, by Technology, Through 2028
Table 2 : Main Orally Disintegrating Drug Delivery Technologies
Table 3 : Comparison of Different Orally Disintegrating Drug Delivery Technologies
Table 4 : Drugs Qualified for Fast-Dissolving Tablet
Table 5 : Examples of Drugs Using Orally Disintegrating Drug Delivery Technologies
Table 6 : List of Commercially Available Fast Dissolving Tablets (FDTs)
Table 7 : List of Commercially Available Fast Dissolving Oral Films
Table 8 : Difference Between Sustained vs. Controlled Drug Delivery
Table 9 : Classic Methods of Extended-Release Delivery Systems and Their Limitations
Table 10 : Examples of Companies Developing Extended Drug Delivery Systems
Table 11 : Global Market for Extended-Release Drug Delivery Systems, by Type, Through 2028
Table 12 : Examples of Delivery Carriers for Targeted Drug Delivery Systems
Table 13 : Examples of FDA-Approved ADC Drugs
Table 14 : Examples of Current U.S. FDA-Approved Nanoparticles and Type of Targeting Employed, Indications, Advantages and Drawbacks
Table 15 : Examples of Companies Developing Targeted Drug Delivery Systems
Table 16 : Examples of Diseases that Require Pulsatile Drug Delivery Systems
Table 17 : Examples of FDA-Approved Advanced Pulsatile Drug Delivery Systems
Table 18 : Examples of Pulsatile Drug Delivery Systems on the Market and the Market Players That Developed Them
Table 19 : Advantages and Disadvantages of Different Routes of Drug Administration
Table 20 : Global Market for Advanced Drug Delivery Systems, by Route of Administration, Through 2028
Table 21 : Some Oral Advanced Drug Delivery Systems
Table 22 : Examples of Specialized Parenteral Routes of Administration
Table 23 : Transmucosal Drug Delivery
Table 24 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, Through 2028
Table 25 : Global Market for Advanced Transmucosal Nasal and Pulmonary Drug Delivery Systems, Through 2028
Table 26 : Examples of Hydrogels and Composites Developed for Ocular Drug Delivery
Table 27 : Global Market for Advanced Ocular Advanced Drug Delivery Systems, Through 2028
Table 28 : Examples of Rectal Formulations Clinically Approved
Table 29 : Global Market for Advanced Rectal Advanced Drug Delivery Systems, Through 2028
Table 30 : Examples of Marketed Medications Delivered, by the Oral-Buccal Route of Administration
Table 31 : Global Market for Advanced Oral Buccal Drug Delivery Systems, Through 2028
Table 32 : Global Market for Advanced Vaginal Drug Delivery Systems, Through 2028
Table 33 : Examples of Implantable Drug Devices on the Market
Table 34 : FDA-Approved Transdermal Patches
Table 35 : Types of Topical Medications
Table 36 : Examples of Advanced Topical Drug Delivery Systems In Clinical Use
Table 37 : Global Market for Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, Through 2028
Table 38 : Examples of Nanocarriers in Drug Delivery and Their Characteristics
Table 39 : Examples of FDA-Approved Nanodrugs Available for Clinical Use
Table 40 : Examples of Clinically Approved Liposome-Based Therapeutics on the Market
Table 41 : Some Liposomal Products Approved, by FDA and EMA
Table 42 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, Through 2028
Table 43 : Examples of Dendrimer-Drug Interactions in Cancer Therapy
Table 44 : Examples of Polymer Drugs Commercially Available
Table 45 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drug, 2022
Table 46 : Examples of Stimuli-Responsive Polymeric Micelles for Cancer Therapy
Table 47 : Examples of FDA-Approved Prodrugs on the Market
Table 48 : Comparison of Control Release Devices
Table 49 : Ten Leading Causes of Death Globally, 2021
Table 50 : Global Market for Advanced Drug Delivery Systems, by Application, Through 2028
Table 51 : Worldwide Cancer Incidence, by Type, 2020
Table 52 : Examples of Different Systems Used in the Cardiovascular Delivery of Therapeutics
Table 53 : Examples of Ophthalmology Drug Delivery Systems
Table 54 : Examples of Marketed Nanopharmaceuticals for Brain Disorders
Table 55 : Examples of Nanoplatforms for Drug Delivery Approved, by the FDA, EMA and Other Organizations
Table 56 : Examples of Antibacterial Drug Delivery Systems
Table 57 : Key Facts and Latest Data for Diabetes Globally, 2021 and 2045
Table 58 : Commercially Available Insulin Injector Pens & Manufacturers
Table 59 : Examples of Drug Delivery Systems for Diabetes Treatment
Table 60 : Prevalence of End Stage Renal Disease, by Country, 2020
Table 61 : Examples of Gastro-Retentive Products Available in the Market
Table 62 : Global Market for Advanced Drug Delivery Systems, by Region, Through 2028
Table 63 : Cancer Incidence in Europe, by Select Countries, 2022
Table 64 : ESG: Environmental Overview
Table 65 : ESG: Social Overview
Table 66 : ESG: Governance Overview
Table 67 : ESG Rankings for Major ADDS Companies, 2023*
Table 68 : Research Projects Using 3D Printing Techniques to Design Drug Delivery Systems
Table 69 : List of Smart Drug Delivery Systems
Table 70 : Clinical Trials in Drug Delivery System, by Type of Study, as of November 2023
Table 71 : Clinical Trials in Drug Delivery System, by Status, as of November 2023
Table 72 : Clinical Trials in Drug Delivery System, by Phase, as of November 2023
Table 73 : Clinical Trials in Drug Delivery System, by Region, November 2023
Table 74 : Patents Granted for Drug Delivery Systems, by Top Applicant, 2018-2022
Table 75 : Patents Granted for Drug Delivery Systems, by Top Owner, 2018-2022
Table 76 : Patents Granted for Drug Delivery Systems, by Jurisdiction, 2018-2022
Table 77 : Advanced Drug Delivery Systems: Market Player Ranking
Table 78 : Recent Developments in Global Market for Advanced Drug Delivery Systems, 2020-2023
Table 79 : Abbott: Company Snapshot
Table 80 : Abbott: Financials, 2021 and 2022
Table 81 : Abbott: Product Portfolio
Table 82 : Abbott: Key Developments, 2021
Table 83 : AbbVie Inc.: Company Snapshot
Table 84 : AbbVie Inc.: Financials, 2021 and 2022
Table 85 : AbbVie Inc.: Key Developments, 2020
Table 86 : AstraZeneca: Company Snapshot
Table 87 : BD: Company Snapshot
Table 88 : BD: Financials, 2021 and 2022
Table 89 : BD: Product Portfolio
Table 90 : BD: Key Developments, 2021-2023
Table 91 : Boston Scientific Corp.: Company Snapshot
Table 92 : Boston Scientific Corp.: Financials, 2021 and 2022
Table 93 : Boston Scientific Corp.: Product Portfolio
Table 94 : Boston Scientific Corp.: Key Developments, 2022
Table 95 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 96 : F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
Table 97 : Johnson & Johnson Services Inc.: Company Snapshot
Table 98 : Johnson & Johnson Services Inc.: Financials, 2021 and 2022
Table 99 : Johnson & Johnson Services Inc.: Key Developments, 2022
Table 100 : Kindeva Drug Delivery: Company Snapshot
Table 101 : Medtronic plc: Company Snapshot
Table 102 : Medtronic plc: Financials, 2021 and 2022
Table 103 : Medtronic plc: Product Portfolio
Table 104 : Medtronic plc: Key Developments, 2023
Table 105 : Merck & Co. Inc.: Company Snapshot
Table 106 : Merck & Co. Inc.: Financials, 2021 and 2022
Table 107 : Novartis AG: Company Snapshot
Table 108 : Novartis AG: Financials, 2021 and 2022
Table 109 : Novartis AG: Key Developments, 2020-2022
Table 110 : Pfizer Inc.: Company Snapshot
Table 111 : Pfizer Inc.: Financials, 2021 and 2022
Table 112 : Sanofi S.A.: Company Snapshot
Table 113 : Sanofi S.A.: Financials, 2021 and 2022
Table 114 : Terumo Corp.: Company Snapshot
Table 115 : Terumo Corp.: Product Portfolio
Table 116 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 117 : Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
Table 118 : Acronyms Used in This Report

List of Figures

Summary Figure A : Global Market for Advanced Drug Delivery Systems, by Technology, 2020-2028
Summary Figure B : Global Market for Advanced Drug Delivery Systems, by Region, 2020-2028
Figure 1 : Conventional vs. Advanced Drug Delivery
Figure 2 : Conventional vs. Advanced Dosage Forms
Figure 3 : Evolution of Advanced Drug Delivery System, Since 1950s
Figure 4 : Global Markets and Technologies for Advanced Drug Delivery Systems Market Dynamics
Figure 5 : Categories of Therapeutic and Delivery Approaches
Figure 6 : Global Market for Advanced Drug Delivery Systems, by Technology
Figure 7 : Global Market Shares of Advanced Drug Delivery Systems, by Technology, 2022
Figure 8 : Global Market for Immediate Drug Release Technology, 2020-2028
Figure 9 : Extended Drug Delivery, by Type
Figure 10 : Global Market for Extended-Release Drug Delivery Systems, 2020-2028
Figure 11 : Global Market for Extended-Release Drug Delivery Systems, by Type, 2020-2028
Figure 12 : Global Market for Targeted-Release Drug Delivery Systems, 2020-2028
Figure 13 : Global Market for Delayed-Release Drug Delivery Systems, 2020-2028
Figure 14 : Global Market for Pulsatile Release Drug Delivery Systems, 2020-2028
Figure 15 : Global Market Shares of Advanced Drug Delivery Systems, by Route of Administration, 2022
Figure 16 : Oral Drug Delivery: Market Overview
Figure 17 : Global Market for Oral Advanced Drug Delivery Systems, 2020-2028
Figure 18 : Global Market for Parenteral/Injectable Advanced Drug Delivery Systems, 2020-2028
Figure 19 : Global Market for Advanced Transmucosal Drug Delivery Systems, 2020-2028
Figure 20 : Global Market for Advanced Transmucosal Drug Delivery Systems, by Type, 2020-2028
Figure 21 : Global Market for Advanced Implant Drug Delivery Systems, 2020-2028
Figure 22 : Global Market for Advanced Transdermal Drug Delivery Systems, 2020-2028
Figure 23 : Global Market for Advanced Topical Drug Delivery Systems, 2020-2028
Figure 24 : Global Market Shares of Advanced Drug Delivery Systems, by Drug Delivery Vehicle/Carrier, 2022
Figure 25 : Global Market for Nanoparticles for Advanced Drug Delivery Systems, 2020-2028
Figure 26 : Global Market for Monoclonal Antibodies for Advanced Drug Delivery Devices, 2020-2028
Figure 27 : Global Market for Liposomes for Advanced Drug Delivery Systems, 2020-2028
Figure 28 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Systems, 2020-2028
Figure 29 : Global Market for Polymeric Therapeutics for Advanced Drug Delivery Devices, 2020-2028
Figure 30 : Global Market Shares of Advanced Drug Delivery Systems, by Type of Polymeric Drugs, 2022
Figure 31 : Global Market for Prodrugs for Advanced Drug Delivery Devices, 2020-2028
Figure 32 : Global Market for Microparticles/Microspheres for Advanced Drug Delivery Devices, 2020-2028
Figure 33 : Global Market for Other Drug Delivery Vehicles/Carriers for Advanced Drug Delivery Systems, 2020-2028
Figure 34 : Global Market Shares of Advanced Drug Delivery Systems, by Application, 2022
Figure 35 : Global Market for Advanced Drug Delivery Systems in Oncology Applications, 2020-2028
Figure 36 : Global Market for Advanced Drug Delivery Systems in Inflammatory and Allergy Applications, 2020-2028
Figure 37 : Global Market for Advanced Drug Delivery Systems in Cardiovascular Applications, 2020-2028
Figure 38 : Global Market for Advanced Drug Delivery Systems in Ophthalmic Applications, 2020-2028
Figure 39 : Global Market for Advanced Drug Delivery Systems in Central Nervous System Applications, 2020-2028
Figure 40 : Global Market for Advanced Drug Delivery Systems in Hormone Replacement Therapy and Gynecological Applications, 2020-2028
Figure 41 : Influenza Burden Estimates in the U.S., October 2022 to April 2023
Figure 42 : Global Market for Advanced Drug Delivery Systems in Viral and Bacterial Diseases Applications, 2020-2028
Figure 43 : Global Market for Advanced Drug Delivery Systems in Diabetes Applications, 2020-2028
Figure 44 : Global Market for Advanced Drug Delivery Systems in Urology Applications, 2020-2028
Figure 45 : Global Market for Advanced Drug Delivery Systems in Gastrointestinal Disorder Applications, 2020-2028
Figure 46 : Global Market for Advanced Drug Delivery Systems in Dermatology Applications, 2020-2028
Figure 47 : Global Market for Advanced Drug Delivery Systems in Respiratory Applications, 2020-2028
Figure 48 : Global Market for Advanced Drug Delivery Systems in Other Therapeutic Applications, 2020-2028
Figure 49 : Global Market Shares of Advanced Drug Delivery Systems, by Region, 2022
Figure 50 : North American Market for Advanced Drug Delivery Systems, 2020-2028
Figure 51 : European Market for Advanced Drug Delivery Systems, 2020-2028
Figure 52 : Asia-Pacific Market for Advanced Drug Delivery Systems, 2020-2028
Figure 53 : Rest of the World Market for Advanced Drug Delivery Systems, 2020-2028
Figure 54 : ESG Pillars
Figure 55 : Advantages of ESG for Biopharmaceutical Companies
Figure 56 : ESG-Adoption Level Across All the Industries, Global, 2021 and 2022
Figure 57 : Hospitals: Sustainability Priorities
Figure 58 : Novartis: Major ESG Activities, 2022
Figure 59 : Patents Granted for Drug Delivery Systems, by Year, 2018-2022
Figure 60 : Major Pharmaceutical Players in the ADDS Market
Figure 61 : Major Medical Device Players in the ADDS Market
Figure 62 : Major CDMO Players in the ADDS Market
Figure 63 : Major CDMO Players in the ADDS Market
Figure 64 : Abbott: Revenue Share, by Business Unit, 2022
Figure 65 : Abbott: Revenue Share, by Region, 2022
Figure 66 : AbbVie Inc.: Financials, 2021 and 2022
Figure 67 : AbbVie Inc.: Revenue Share, by Business Unit, 2022
Figure 68 : AbbVie Inc.: Revenue Share, by Region, 2022
Figure 69 : BD: Financials, 2021 and 2022
Figure 70 : BD: Revenue Share, by Business Unit, 2022
Figure 71 : BD: Revenue Share, by Region, 2022
Figure 72 : Boston Scientific Corp.: Financials, 2021 and 2022
Figure 73 : Boston Scientific Corp.: Revenue Share, by Business Unit, 2022
Figure 74 : Boston Scientific Corp.: Revenue Share, by Country/Region, 2022
Figure 75 : F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
Figure 76 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, 2022
Figure 77 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2022
Figure 78 : Johnson & Johnson Services Inc.: Financials, 2021 and 2022
Figure 79 : Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2022
Figure 80 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, 2022
Figure 81 : Medtronic plc: Financials, 2021 and 2022
Figure 82 : Medtronic plc: Market Share, by Business Unit, 2022
Figure 83 : Medtronic plc: Market Share, by Region, 2022
Figure 84 : Merck & Co. Inc.: Financials, 2021 and 2022
Figure 85 : Merck & Co. Inc.: Revenue Share, by Business Unit, 2022
Figure 86 : Merck & Co. Inc.: Revenue Share, by Country/Region, 2022
Figure 87 : Novartis AG: Financials, 2021 and 2022
Figure 88 : Novartis AG: Revenue Share, by Business Unit, 2022
Figure 89 : Novartis AG: Revenue Share, by Region, 2022
Figure 90 : Pfizer Inc.: Financials, 2021 and 2022
Figure 91 : Pfizer Inc.: Revenue Share, by Business Unit, 2022
Figure 92 : Pfizer Inc.: Revenue Share, by Region, 2022
Figure 93 : Sanofi S.A.: Financials, 2021 and 2022
Figure 94 : Sanofi S.A.: Revenue Share, by Business Unit, 2022
Figure 95 : Sanofi S.A.: Revenue Share, by Region, 2022 (%)
Figure 96 : Teva Pharmaceutical Industries Ltd.: Financials, 2021 and 2022
Figure 97 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, 2022
Figure 98 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2022